Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. - Wikidata - wikimedia - TriplyDB

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

http://www.wikidata.org/entity/Q45178457

about

The multidrug transporter ABCG2: still more questions than answers Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies The FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactions Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML).Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma.Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).The challenge of exploiting ABCG2 in the clinic.ABCG2: a perspective.Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo.ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistance ABCG2 expression, function, and promoter methylation in human multiple myeloma Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.Drug resistance: still a daunting challenge to the successful treatment of AML.Molecular diagnosis of ATP-binding cassette transporter-related diseases.DualChip microarray as a new tool in cancer research.Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).Prognostic impact of membranous ATP-binding cassette Sub-family G member 2 expression in patients with colorectal carcinoma after surgical resection.Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics.ABCG2: the key to chemoresistance in cancer stem cells?The ABCG family of membrane-associated transporters: you don't have to be big to be mighty The controversial role of ABC transporters in clinical oncology.Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.

P2860

Q26747187-44540747-82B9-42C9-B175-CBF0D15810A5 Q26853528-AECAC832-099F-469C-A326-983328FBF0AA Q26865927-CE6F137A-7C13-4191-AE63-CB7385F32E77 Q28067499-5B601480-DB87-4F0A-8A1D-4403DBFF25B9 Q28535342-C0292F88-DFBF-41E2-ADF6-1C244A96A4DD Q30439828-31D812B7-22C3-4B0B-A299-165EB7A26445 Q33257856-B64F2B5B-7BDD-4AA6-B36D-6AD5D5F73526 Q33281867-0552702E-4FE0-49AF-83AC-3A6104982331 Q33319637-E9E9E007-F8CA-4BA5-A22E-570F93CC81A2 Q33476723-D97FF0D6-D819-4294-8FB9-F9853578FA83 Q33934046-5998EEB8-8123-434E-AEE9-226D784450D2 Q33934534-52CCB666-57DB-44D2-9851-D20FDF60B3A7 Q34176588-CC5CAFB7-3F95-4D3E-AC51-20F1D80BC2B9 Q34204238-7B844B36-0853-48D2-9027-F5794CA41AB2 Q34704841-9DC0C7BC-F7C2-41A1-918A-4E9A1F975B92 Q34743441-22244FA3-61B2-4A4E-9F91-768331215B7C Q34968909-6EC77928-5C96-4321-883C-5C2F88B14086 Q35016817-6C645123-41D8-48D5-A3FD-9C87759F0091 Q35067898-2768EDD8-7E6E-41EA-AE8E-9EE3F156D4B4 Q35190691-E1EB2D1E-6585-435F-BF57-8C7FAF2D0D84 Q35193725-2569D817-9367-41AD-816F-27D390B12F92 Q35776784-9201FDD4-7D13-481A-A9B2-101FD01C39BE Q35848835-4DC3D04E-1634-40BA-80EB-8793A21E6939 Q35848938-84AC8505-1634-475E-81E0-A8E6896D1FFB Q35880840-56426079-9ABB-4EFA-9CA9-AB517AA83354 Q35946969-D6F8A8BC-EADB-42BB-B1C6-809A2692F4DE Q36252201-49E2E3AB-38C4-46A1-B711-609F76717B82 Q36481097-6C400BD0-89C9-427D-B9BD-8B810FC264B4 Q36771977-20402BB6-B422-44B7-BEB6-3E599CB56DED Q36838947-98B7B3E6-236E-42A5-A241-88D938A92127 Q37219909-4171416E-5532-4A3F-B2BB-65AD2910BF4C Q37241606-2B02C8FB-EDA4-464E-9356-0764ECB26670 Q37250469-4F951544-F76D-451E-8BE7-9781AA492B28 Q37289700-129B5EC4-7149-4DCB-8D08-7961E2CE99F5 Q37415822-F45BD038-E612-4E9B-9648-E6EE4B5B4174 Q37563366-F609CD26-2BA7-427D-8F26-412F50031B76 Q37587219-E4A7AE04-9AC6-4F89-BAFC-7C5A61584864 Q37822832-A576242F-C63A-4D3F-B2D3-C86FF5B2DF2D Q37941758-0866B7C6-9114-4793-A7F3-9E0849C77D2C Q37958162-8F774260-C54B-476D-99A5-83B506098D72

P2860

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

http://www.wikidata.org/entity/Q45178457

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

@en

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

@nl

type

label

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

@en

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

@nl

prefLabel

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

@en

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

@nl

P1433

Q45178457-A5F32BC8-0C4F-4EBA-9840-C69648743B8C

P1476

Q45178457-4B2BEFB6-ABD2-43D1-B8B6-CC6FAF5CE7F3

P2093

Q45178457-559ECF80-FB69-4D91-A119-05BDCB063339

Q45178457-57958A4E-98E6-4B30-B2BF-71D7EEF2A452

Q45178457-788B0691-4DF9-4461-97FD-00E2F052DAA5

Q45178457-94A22035-7BE3-4322-A6B5-D159879C1DE7

Q45178457-9CDC7490-CD12-4A6A-AF62-68C845388C52

Q45178457-A399B794-D041-49C0-8961-E4FC6F5081A5

Q45178457-DA9D4AE6-21FC-412C-B6B2-20049CEF55C6

P304

Q45178457-C43C4854-6CDF-4DD1-A639-E7CD17999F3B

P31

Q45178457-61346957-3089-4573-ABF9-4473D179DB11

P356

Q45178457-C6FCECEE-1813-47F1-BB00-D0EED2D3FBC3

P407

Q45178457-1580CE1C-8846-4E06-8087-1269060ED49A

P433

Q45178457-FE46CBCC-BCB6-4D7D-B105-6AAFE3620691

P478

Q45178457-EF1FF525-6A0A-4254-A734-F522E153D737

P577

Q45178457-1D6DC273-E27B-447A-AEE7-FAB7DC4A9C64

P698

Q45178457-40BFEFCE-7705-419B-B82B-2A725183EE1B

P356

1078-0432.CCR-04-0795

P1433

Clinical Cancer Research

P1476

Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

@en

P2093

Anne-Marie Faussat

http://www.w3.org/2001/XMLSchema#string

Driss Chaoui

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Marie

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Perrot

http://www.w3.org/2001/XMLSchema#string

Lydia Sayada

http://www.w3.org/2001/XMLSchema#string

Ollivier Legrand

http://www.w3.org/2001/XMLSchema#string

Zineb Benderra

http://www.w3.org/2001/XMLSchema#string

P304

7896-7902

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-04-0795

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15585622

http://www.w3.org/2001/XMLSchema#string